| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Northcut Jacqueline serves as a Director at MBRX. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $820 at current prices.
The biggest single holding is MBRX (~$820) as Director. Net of sales, the recent Form 4 record there shows accumulation of 1,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 5, 2017 | MBRX Moleculin Biotech, Inc. | Director | Buy | 1,000 | $0.82 | $820.00 | New |